Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.
This article is from
The Cancer Letter
archive.
Vol. 26 No. 46 | December 15, 2000
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
New NCI Directory
May 19, 1989
Primary Source
NCCS Networker Volume 8 Issue 3, Fall 1994
September 12, 1994
TCL Archive
Doubling Budget For NSF High Priority For FASEB.
April 20, 2001
TCL Archive
Breast Cancer Action Claims “Victory On Avastin.”
December 14, 2007
TCL Archive
Momentum Continues For Private Development Of Free Standing Cancer Centers
July 19, 1985
TCL Archive
Tacoma Hospital Finds Cancer DRGs Are Profitable
February 17, 1984
